David A. Barbie

Active 1996–2025

92
Papers
23,016
Citations
59
h-index
88
i10-index

Citations

Citations per year for David A. Barbie1976: 1 citations1997: 6 citations1998: 3 citations1999: 5 citations2000: 17 citations2001: 43 citations2002: 60 citations2003: 55 citations2004: 41 citations2005: 50 citations2006: 53 citations2007: 41 citations2008: 41 citations2009: 51 citations2010: 106 citations2011: 109 citations2012: 89 citations2013: 93 citations2014: 100 citations2015: 132 citations2016: 203 citations2017: 192 citations2018: 273 citations2019: 934 citations2020: 1,287 citations2021: 1,468 citations2022: 1,338 citations2023: 1,170 citations2024: 1,683 citations2025: 1,013 citations2026: 41 citations1977–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,519 citing papers, 30.6% of this breakdownChina: 2,702 citing papers, 18.3% of this breakdownUnited Kingdom: 769 citing papers, 5.2% of this breakdownGermany: 670 citing papers, 4.5% of this breakdownItaly: 531 citing papers, 3.6% of this breakdownFrance: 474 citing papers, 3.2% of this breakdownCanada: 417 citing papers, 2.8% of this breakdownJapan: 400 citing papers, 2.7% of this breakdownAustralia: 358 citing papers, 2.4% of this breakdownSpain: 355 citing papers, 2.4% of this breakdownNetherlands: 318 citing papers, 2.2% of this breakdownSwitzerland: 316 citing papers, 2.2% of this breakdown
0%30.6%Other 19.9%

Fields

  • Medicine48.1%
  • Biochemistry, Genetics and Molecular Biology34.6%
  • Immunology and Microbiology12.6%
  • Engineering2.3%
  • Computer Science0.5%
  • Chemistry0.5%
  • Other1.4%

Topics

  • Cancer Immunotherapy and Biomarkers9%
  • Immunotherapy and Immune Responses4.1%
  • CAR-T cell therapy research3.5%
  • Immune Cell Function and Interaction3.5%
  • Cancer Genomics and Diagnostics3.2%
  • Immune cells in cancer3%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jill P. Mesirov, David E. Root, D. Gary Gilliland, Tyler Jacks, William C. Hahn - Nature 2009 cited by 4,263

  2. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 cited by 2,103

  3. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Israel Cañadas, Bastian Schilling, Adam N.R. Cartwright, Adrienne Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A. Barbie, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai W. Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev - Cell 2018 cited by 1,482

  4. Mechanisms of resistance to immune checkpoint inhibitors

    Authors: , , - British Journal of Cancer 2018 cited by 1,356

  5. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 cited by 367

  6. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rameen Beroukhim, Pratiti Bandopadhayay, Mark M. Awad, Prafulla C. Gokhale, Paul T. Kirschmeier, Jarrod A. Marto, Fernando D. Camargo, Rizwan Haq, Cloud P. Paweletz, Kwok‐Kin Wong, David A. Barbie, Henry W. Long, Nathanael S. Gray, Pasi A. Jänne - Cancer Cell 2020 cited by 472

  7. Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lauren Keogh, María Anguiano, Lance Stapleton, Zhiheng Jia, Michal Barzily-Rokni, Israel Cañadas, Tran C. Thai, Marc R. Hammond, Raven Vlahos, Eric S. Wang, Hua Zhang, Shuai Li, Glenn J. Hanna, Wei Huang, Mai P. Hoang, Adriano Piris, Jean-Pierre Eliane, Anat Stemmer‐Rachamimov, Lisa Cameron, Mei-Ju Su, Parin Shah, Benjamin Izar, Manisha Thakuria, Nicole R. LeBoeuf, Guilherme Rabinowits, Viswanath Gunda, Sareh Parangi, James M. Cleary, Brian C. Miller, Shunsuke Kitajima, Rohit Thummalapalli, Benchun Miao, Thanh U. Barbie, Vivek Sivathanu, Joshua A. Wong, William G. Richards, Raphael Bueno, Charles H. Yoon, Juan J. Miret, Meenhard Herlyn, Levi A. Garraway, Eliezer M. Van Allen, Gordon J. Freeman, Paul T. Kirschmeier, Jochen H. Lorch, Patrick A. Ott, F. Stephen Hodi, Keith T. Flaherty, Roger D. Kamm, Genevieve M. Boland, Kwok‐Kin Wong, David Dornan, Cloud P. Paweletz, David A. Barbie - Cancer Discovery 2017 cited by 585

  8. CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay C. Strum, William G. Richards, Jochen H. Lorch, Sareh Parangi, Viswanath Gunda, Genevieve M. Boland, Raphael Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Jerome Ritz, W. Nicholas Haining, Norman E. Sharpless, Haribabu Arthanari, Geoffrey I. Shapiro, David A. Barbie, Nathanael S. Gray, Kwok‐Kin Wong - Cancer Discovery 2017 cited by 781

  9. Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer

    Authors: , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 515

  10. STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Glenn Dranoff, Peter S. Hammerman, Kwok‐Kin Wong - Cancer Research 2016 cited by 630

  11. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 cited by 214

  12. STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 167

  13. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Housheng Hansen He, Matthew L. Freedman, Steven P. Balk, Massimo Loda, David P. Labbé, Brian M. Olson, Leigh Ellis - Nature Cancer 2021 cited by 241

  14. Targeting TBK1 to overcome resistance to cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie‐Hurder, Jonathan Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena V. Ivanova, Amir Reza Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso, Russell W. Jenkins - Nature 2023 cited by 167

  15. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen - Nature Genetics 2018 cited by 696

  16. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynnette Marie Sholl, Ewa Sicińska, Jacob Sands, Scott J. Rodig, Kwok‐Kin Wong, Cloud P. Paweletz, Hideo Watanabe, David A. Barbie - Nature Medicine 2018 cited by 317

  17. TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2024 cited by 94

  18. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 101

  19. 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Lab on a Chip 2018 cited by 251

  20. Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2019 cited by 238

  21. Activation of Tumor-Cell STING Primes NK-Cell Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pınar Ö. Eser, Zehua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G. Richards, Adnan O. Abu‐Yousif, Vicky A. Appleman, Richard C. Gregory, Alexander Parent, Neil Lineberry, Eric L. Smith, Pasi A. Jänne, Juan J. Miret, Michael Tolstorukov, Rizwan Romee, Cloud P. Paweletz, Raphael Bueno, David A. Barbie - Cancer Immunology Research 2022 cited by 88

  22. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay

    Authors: , , , , , , , , , - Advanced Healthcare Materials 2022 cited by 81

  23. Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark M. Awad, Jia Luo - Annals of Oncology 2022 cited by 101

  24. Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricardo De Matos Simoes, Matti Kankainen, Constantine S. Mitsiades, Satu Mustjoki - Immunity 2023 cited by 66